Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 10, 2023

BUY
$1.05 - $1.63 $14,299 - $22,198
13,619 Added 17.51%
91,403 $103,000
Q1 2023

Apr 25, 2023

BUY
$1.2 - $2.73 $16,653 - $37,886
13,878 Added 21.72%
77,784 $105,000
Q4 2022

Feb 03, 2023

SELL
$1.71 - $3.61 $131 - $277
-77 Reduced 0.12%
63,906 $118,000
Q3 2022

Nov 07, 2022

BUY
$1.9 - $8.63 $11,116 - $50,494
5,851 Added 10.07%
63,983 $157,000
Q2 2022

Jul 28, 2022

SELL
$2.13 - $9.01 $1,344 - $5,685
-631 Reduced 1.07%
58,132 $142,000
Q1 2022

May 12, 2022

BUY
$6.28 - $15.59 $31,757 - $78,838
5,057 Added 9.42%
58,763 $468,000
Q4 2021

Jan 31, 2022

SELL
$14.7 - $28.67 $101,841 - $198,625
-6,928 Reduced 11.43%
53,706 $820,000
Q3 2021

Nov 15, 2021

BUY
$24.31 - $33.6 $1.32 Million - $1.82 Million
54,184 Added 840.06%
60,634 $1.72 Million
Q2 2021

Aug 10, 2021

BUY
$26.09 - $40.4 $2,609 - $4,040
100 Added 1.57%
6,450 $218,000
Q1 2021

May 07, 2021

BUY
$33.06 - $56.93 $209,931 - $361,505
6,350 New
6,350 $243,000
Q4 2019

Feb 14, 2020

SELL
$15.02 - $20.57 $524,303 - $718,036
-34,907 Closed
0 $0
Q3 2019

Nov 05, 2019

SELL
$18.85 - $27.5 $11,668 - $17,022
-619 Reduced 1.74%
34,907 $673,000
Q2 2019

Aug 13, 2019

BUY
$17.37 - $26.27 $1,980 - $2,994
114 Added 0.32%
35,526 $835,000
Q1 2019

May 13, 2019

BUY
$10.65 - $25.75 $377,137 - $911,859
35,412 New
35,412 $829,000

Others Institutions Holding NVTA

About Invitae Corp


  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track D.A. Davidson & Co. Portfolio

Follow D.A. Davidson & Co. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of D.A. Davidson & Co., based on Form 13F filings with the SEC.

News

Stay updated on D.A. Davidson & Co. with notifications on news.